Global Loxapine succinate salt (CAS 27833-64-3) Market Report 2019 - History, Present and Future. Published On :12 Feb 2019 Report Code :GRS3588991 Technical Service: Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others. 5-HT Receptor MedChem Express HY-17390: GPCR/G protein MedChem Express HY-17390: GPCR/G protein; Neuronal Signaling; MedChem Express HY-17390: Loxapine Succinate is a D2DR and D4DR inhibitor, serotonergic receptor antagonist and also a dibenzoxazepine anti-psychotic agent. ChemicalBook provide Chemical industry users with Loxapine succinate salt Boiling point Melting point,Loxapine succinate salt Density MSDS Formula Use,If You also need to Loxapine succinate salt Other information,welcome to contact us. LOXAPINE (loxapine succinate) Capsule. DESCRIPTION. Loxapine (loxapine succinate), a dibenzoxazepine compound, represents a subclass of tricyclic antipsychotic agents, chemically distinct from the thioxanthenes, butyrophenones, and phenothiazines. Loxapine Succinate is the succinate salt form of loxapine, a tricyclic dibenzoxazepine antipsychotic agent with antiemetic, sedative, anticholinergic, and antiadrenergic actions. 在订购、运输、储存和使用我们的产品的任何阶段，您遇到的任何问题，均可以通过拨打我们的热线电话400-998-7375，或者邮箱 info@tsbiochem.com，直接联系到我们。 Visit ChemicalBook To find more Loxapine succinate salt(27833-64-3) information like chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight, physical properties,toxicity information,customs codes. You can also browse global suppliers,vendor,prices,Price,manufacturers of Loxapine succinate salt(27833. Search results for loxapine at Sigma-Aldrich. Compare Products: Select up to 4 products. *Please select more than one item to compare It is present as the succinate salt. Each capsule for oral administration, contains Loxapine succinate, USP, 6.8 mg, 13.6 mg, 34 mg or 68 mg equivalent to 5 mg, 10 mg, 25 mg, or 50 mg of Loxapine base, respectively.